Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Copeland

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|August 1, 1985
Eating disordersD B Herzog, P M Copeland
The American Journal of the Medical Sciences|January 1, 1986
Cysteamine decreases prolactin responsiveness to thyrotropin-releasing hormone in normal menP M Copeland, J B Martin, E C Ridgway
Life Sciences|November 15, 1977
Segmental norepinephrine and dopamine levels in cat spinal cordS E Rawe, P M Copeland, R H Roth
Psychosomatic Medicine|March 1, 1995
Longitudinal follow-up of amenorrhea in eating disordersP M Copeland, N R Sacks, D B Herzog
The American Journal of Psychiatry|August 1, 1989
Neurochemical abnormalities of anorexia nervosa and bulimia nervosaM Fava, P M Copeland, U Schweiger, et al.
Psychoneuroendocrinology|January 1, 1988
Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal womenP M Copeland, D B Herzog, D B Carr, et al.
Acta Psychiatrica Scandinavica|January 21, 2006
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophreniaD C Henderson, P M Copeland, D D Nguyen, et al.
Acta Psychiatrica Scandinavica|February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophreniaD C Henderson, X Fan, B Sharma, et al.
Acta Psychiatrica Scandinavica|January 25, 2007
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gainD C Henderson, X Fan, P M Copeland, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|August 1, 1985
Eating disordersD B Herzog, P M Copeland
The American Journal of the Medical Sciences|January 1, 1986
Cysteamine decreases prolactin responsiveness to thyrotropin-releasing hormone in normal menP M Copeland, J B Martin, E C Ridgway
Life Sciences|November 15, 1977
Segmental norepinephrine and dopamine levels in cat spinal cordS E Rawe, P M Copeland, R H Roth
Psychosomatic Medicine|March 1, 1995
Longitudinal follow-up of amenorrhea in eating disordersP M Copeland, N R Sacks, D B Herzog
The American Journal of Psychiatry|August 1, 1989
Neurochemical abnormalities of anorexia nervosa and bulimia nervosaM Fava, P M Copeland, U Schweiger, et al.
Psychoneuroendocrinology|January 1, 1988
Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal womenP M Copeland, D B Herzog, D B Carr, et al.
Acta Psychiatrica Scandinavica|January 21, 2006
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophreniaD C Henderson, P M Copeland, D D Nguyen, et al.
Acta Psychiatrica Scandinavica|February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophreniaD C Henderson, X Fan, B Sharma, et al.
Acta Psychiatrica Scandinavica|January 25, 2007
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gainD C Henderson, X Fan, P M Copeland, et al.
Pageof 2